Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1989 4
1990 1
2000 1
2004 2
2005 1
2007 1
2009 1
2010 6
2011 6
2012 6
2013 9
2014 9
2015 9
2016 4
2017 4
2018 5
2019 7
2020 5
2021 9
2022 3
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular events and intensity of treatment in polycythemia vera.
Marchioli R, Finazzi G, Specchia G, Cacciola R, Cavazzina R, Cilloni D, De Stefano V, Elli E, Iurlo A, Latagliata R, Lunghi F, Lunghi M, Marfisi RM, Musto P, Masciulli A, Musolino C, Cascavilla N, Quarta G, Randi ML, Rapezzi D, Ruggeri M, Rumi E, Scortechini AR, Santini S, Scarano M, Siragusa S, Spadea A, Tieghi A, Angelucci E, Visani G, Vannucchi AM, Barbui T; CYTO-PV Collaborative Group. Marchioli R, et al. N Engl J Med. 2013 Jan 3;368(1):22-33. doi: 10.1056/NEJMoa1208500. Epub 2012 Dec 8. N Engl J Med. 2013. PMID: 23216616 Free article. Clinical Trial.
The metabolomic signature of hematologic malignancies.
Allegra A, Innao V, Gerace D, Bianco O, Musolino C. Allegra A, et al. Among authors: gerace d. Leuk Res. 2016 Oct;49:22-35. doi: 10.1016/j.leukres.2016.08.002. Epub 2016 Aug 8. Leuk Res. 2016. PMID: 27526405 Review.
Nanobodies and Cancer: Current Status and New Perspectives.
Allegra A, Innao V, Gerace D, Vaddinelli D, Allegra AG, Musolino C. Allegra A, et al. Among authors: gerace d. Cancer Invest. 2018 Apr 21;36(4):221-237. doi: 10.1080/07357907.2018.1458858. Epub 2018 Apr 16. Cancer Invest. 2018. PMID: 29658806 Review.
Standardisation of minimal residual disease in multiple myeloma.
Innao V, Allegra A, Russo S, Gerace D, Vaddinelli D, Alonci A, Allegra AG, Musolino C. Innao V, et al. Among authors: gerace d. Eur J Cancer Care (Engl). 2017 Nov;26(6). doi: 10.1111/ecc.12732. Epub 2017 Jul 3. Eur J Cancer Care (Engl). 2017. PMID: 28671297 Review.
New orally active proteasome inhibitors in multiple myeloma.
Allegra A, Alonci A, Gerace D, Russo S, Innao V, Calabrò L, Musolino C. Allegra A, et al. Among authors: gerace d. Leuk Res. 2014 Jan;38(1):1-9. doi: 10.1016/j.leukres.2013.10.018. Epub 2013 Oct 29. Leuk Res. 2014. PMID: 24239172 Review.
87 results